Read review Dihexa for Migraine & Chronic Migraine The May 2024 NICE TA973 atogepant (Aquipta, AbbVie) approval, the rimegepant / erenumab / galcanezumab / fremanezumab / eptinezumab CGRP pathway, 2025 chronic-migraine hippocampal atrophy & accelerated brain ageing research, the Tanure BDNF-elevated-in-attack paradox, NICE NG150, and the ~10 million UK migraine population
Without adequate glutathione, detoxification stalls, oxidative damage accelerates, and the immune system cannot self-regulate effectively
transplanting postoperative patient feces to antibiotic-treated mice effectively resisted diet-induced obesity and NAFLD, and this resistance was associated with reduced GIP levels in mice
When NNMT is overactive, it consumes NAD+ at an accelerated rate
The timeline depends on which peptide you are on, your current health, your age, and how consistently you follow the protocol